Listed

XBiotech Inc.

XBITNasdaqCIK 1626878HealthcareFiscal year ends Dec 31

Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

XBiotech Inc., Reports and events
FiledFormWhat it isAccession number
2021-03-1616:28 ET10-KAnnual reportPeriod 2020-12-310001171843-21-001828
2020-11-0917:28 ET10-QQuarterly reportPeriod 2020-09-300001171843-20-007826
2020-08-1017:24 ET10-QQuarterly reportPeriod 2020-06-300001171843-20-005794
2020-06-2913:14 ET8-K5.07 Shareholder vote results0001171843-20-004608
2020-05-1117:23 ET10-QQuarterly reportPeriod 2020-03-310001171843-20-003601
2020-04-2913:50 ETDEF 14AProxy statementPeriod 2020-06-260001171843-20-002999
2020-03-1617:24 ET10-KAnnual reportPeriod 2019-12-310001171843-20-001761
2019-12-3017:08 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-19-008353
2019-12-0916:28 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-19-008024
2019-11-1211:47 ET10-QQuarterly reportPeriod 2019-09-300001171843-19-007437
2019-08-0915:01 ET10-QQuarterly reportPeriod 2019-06-300001171843-19-005378
2019-07-1612:36 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-19-004604
2019-06-2013:16 ET8-K5.07 Shareholder vote results0001171843-19-004081
2019-06-0316:48 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-19-003792
2019-05-3016:50 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-19-003712
2019-05-3016:19 ET8-K1.02 Termination of a material agreement0001171843-19-003710
2019-05-0914:37 ET10-QQuarterly reportPeriod 2019-03-310001171843-19-003199
2019-05-0117:20 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001171843-19-002822
2019-04-3012:51 ETDEF 14AProxy statementPeriod 2019-06-190001171843-19-002757
2019-04-0316:10 ET8-K1.02 Termination of a material agreement0001171843-19-002224
2019-03-1513:09 ET10-K/AAnnual report, amendedPeriod 2018-12-310001171843-19-001758
2019-03-1420:00 ET10-KAnnual reportPeriod 2018-12-310001171843-19-001708
2018-10-3115:48 ET10-QQuarterly reportPeriod 2018-09-300001171843-18-007413
2018-10-2412:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-18-007152
2018-09-0518:34 ET10-K/AAnnual report, amendedPeriod 2017-12-310001171843-18-006389
2018-09-0517:50 ET10-Q/AQuarterly report, amendedPeriod 2018-03-310001171843-18-006385
2018-08-0912:46 ET10-QQuarterly reportPeriod 2018-06-300001171843-18-005920
2018-07-3115:32 ET10-K/AAnnual report, amendedPeriod 2017-12-310001171843-18-005559
2018-07-3114:30 ET10-Q/AQuarterly report, amendedPeriod 2018-03-310001171843-18-005556
2018-06-2114:18 ET8-K5.07 Shareholder vote results0001171843-18-004776
2018-05-0815:23 ET10-QQuarterly reportPeriod 2018-03-310001171843-18-003654
2018-04-3016:22 ETDEF 14AProxy statementPeriod 2018-04-300001171843-18-003188
2018-04-1115:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001171843-18-002645
2018-03-2312:12 ET8-K8.01 Other events0001171843-18-002228
2018-03-2216:28 ET8-K5.02 Departure or appointment of officers or directors0001171843-18-002197
2018-03-1616:15 ET10-KAnnual reportPeriod 2017-12-310001171843-18-002043
2018-03-0117:12 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001171843-18-001608
2018-01-1918:29 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors0001171843-18-000446
2018-01-0512:14 ET8-K8.01 Other events0001171843-18-000201
2017-11-2207:12 ET8-K8.01 Other events0001171843-17-007231
2017-11-0915:37 ET10-QQuarterly reportPeriod 2017-11-020001171843-17-006828
2017-09-1518:12 ET8-K8.01 Other events0001171843-17-005552
2017-08-0816:51 ET10-QQuarterly reportPeriod 2017-06-300001171843-17-004856
2017-06-2011:44 ET8-K5.07 Shareholder vote results0001171843-17-003698
2017-06-0915:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-003574
2017-05-1816:29 ET8-K8.01 Other events0001171843-17-003181
2017-05-1016:35 ET10-QQuarterly reportPeriod 2017-03-310001171843-17-002928
2017-04-2817:06 ETDEF 14AProxy statementPeriod 2017-06-190001171843-17-002419
2017-04-2811:58 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-002408
2017-04-2118:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-002235

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:14 ET. Listed shows no prices and gives no investment advice.